Detalles de la búsqueda
1.
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.
Blood;
133(10): 1020-1030, 2019 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30404811
2.
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.
Ann Oncol;
29(4): 973-978, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29390048
3.
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upâ.
Ann Oncol;
32(2): 142-156, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221366
4.
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.
Ann Hematol;
95(12): 1971-1978, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650829
5.
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
Ann Hematol;
95(9): 1399-410, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334946
6.
Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study.
Eur J Cancer Care (Engl);
25(5): 839-48, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26526286
7.
Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.
Ann Oncol;
25(2): 447-54, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24478321
8.
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.
Bone Marrow Transplant;
59(2): 232-238, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007531
9.
Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Ann Hematol;
92(2): 191-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23073603
10.
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.
Bone Marrow Transplant;
56(9): 2160-2172, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33911203
11.
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.
Leukemia;
35(3): 835-849, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32595214
12.
[A rare coagulation disorder. Diagnostics and management in cases of hereditary dysfibrinogenemia]. / Seltene Ursache einer hämorrhagischen Diathese. Diagnostik und perioperatives Management bei hereditärer Dysfibrinogenämie.
Internist (Berl);
50(2): 230-4, 2009 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-19043687
13.
[Successful treatment of acquired hemophilia A with recombinant porcine factor VIII]. / Erfolgreiche Behandlung einer erworbenen Hemmkörperhämophilie A mit rekombinantem porcinem Faktor VIII.
Med Klin Intensivmed Notfmed;
114(8): 746-748, 2019 Nov.
Artículo
en Alemán
| MEDLINE | ID: mdl-29774375
14.
Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
Bone Marrow Transplant;
42(2): 113-20, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18362900
15.
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
Ann Hematol;
92(1): 125-7, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22820970
16.
An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.
Biomol Detect Quantif;
15: 6-12, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29349042
17.
The IPSS-R has prognostic impact in untreated patients with MDS del(5q).
Leuk Res;
72: 27-33, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30075323
18.
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial.
Leukemia;
37(11): 2309-2313, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37735558
19.
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia.
Leukemia;
20(4): 707-14, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16482208
20.
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.
Leukemia;
31(9): 1944-1950, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28626220